The mentioned studies have revealed that Lut treatment for COPD might involve modifying the epidermal growth factor receptor (EGFR), matrix metalloproteinase (MMP), and NADPH oxidase (NOX4). Here, NOX4 is linked to chronic obstructive pulmonary disease.